Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZ) Asset Writedowns and Impairment (2022 - 2025)

Core Scientific's Asset Writedowns and Impairment history spans 2 years, with the latest figure at $11.4 million for Q4 2025.

  • For Q4 2025, Asset Writedowns and Impairment changed N/A year-over-year to $11.4 million; the TTM value through Dec 2025 reached $14.4 million, changed N/A, while the annual FY2025 figure was $11.4 million, 90.76% down from the prior year.
  • Asset Writedowns and Impairment for Q4 2025 was $11.4 million at Core Scientific, up from $3.1 million in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $11.4 million in Q4 2025 and bottomed at -$784.8 million in Q3 2022.